College of Pharmacy and Health Sciences
Weaver Medal of Honor Lecture
Timothy Franson, PH'74
Wednesday, April 24, 2013
Sheslow Auditorium, Drake University
2013 Recipient of Weaver Medal of Honor
Toast at 3:45 p.m.
Cowles Library Reading Room
Timothy Franson is currently a principal in FaegreBD Consulting, where he is part of a rare disease team with a long history of providing policy, program development, and consultative support to rare disease stakeholders.
Before joining FaegreBD Consulting, Franson worked as an attending physician and assistant professor of medicine, hospital epidemiologist, and consultant in infectious diseases.
From 1986-2008, he worked with Eli Lilly and Company. First employed as an associate clinical investigator, he retired as vice president of global regulatory affairs at Lilly Research Laboratories, responsible for all regulatory and patient safety activities. Franson then founded and became president of Franson PharmAdvisors LLC, a clinical and regulatory pharmaceutical development consulting firm that merged with FaegreBD Consulting.
Franson was recently selected to serve on the National Institutes of Health’s National Center for Advancing Translational Services' (NCATS) Therapeutics for Rare and Neglected Diseases (TRND) review panel. He was selected, in part, for his extensive experience in clinical and developmental grant reviews. He also serves as president of the U.S. Pharmacopeia Convention.
In addition, Franson has co-chaired FDA-industry committees, was a member of the AAMC-PhRMA Clinical Trials Forum, and has been a member of the Regulatory Advisory Board for the Centre for Medicines Research International. Franson is committed to numerous civic organizations, including serving as on the board of directors for Villages of Indiana and the Little Red Door Cancer Agency. During his career, Franson has authored over 50 articles in the fields of infectious disease, epidemiology, pharmacoeconomics and antibiotic utilization, as well as chapters in three textbooks.